| Model Name | Description |
| LS180 | The LS180 xenograft model is derived from human colorectal adenocarcinoma and is used to study intestinal cancer biology and assess anticancer drug efficacy. |
| HT55 | The HT55 xenograft model is derived from human colorectal adenocarcinoma and is used to evaluate therapies targeting moderately differentiated colon tumors. |
| COLO-320DM | The COLO-320DM xenograft model is derived from human colorectal carcinoma and is used to study non-adherent, drug-resistant colon tumors and test chemotherapies. |
| Caco-2 | The Caco-2 xenograft model is derived from human colorectal adenocarcinoma and is commonly used to evaluate drug absorption, metabolism, and intestinal barrier function. |
| T84 | The T84 xenograft model is derived from human colon carcinoma and is used to study epithelial ion transport, tight junctions, and tumor response to therapy. |
| SW 48 | The SW 48 xenograft model is derived from human colorectal adenocarcinoma and is used to study microsatellite-stable colon cancer and assess targeted treatments. |
| LS411N | The LS411N xenograft model is derived from human colorectal cancer and is used to study moderately differentiated tumors and evaluate experimental therapeutics. |
| COLO 201 | The COLO 201 xenograft model is derived from human colorectal adenocarcinoma and is used to study well-differentiated tumors and test antitumor agents. |
| GP2D | The GP2D xenograft model is derived from human colorectal carcinoma and is used in preclinical studies to evaluate treatments targeting aggressive colon cancer. |
| GP5D | The GP5D xenograft model is derived from human colorectal cancer and is used to study drug sensitivity and tumor progression in colon adenocarcinoma. |
| SW837 | The SW837 xenograft model is derived from human rectal adenocarcinoma and is used to study low-grade rectal tumors and evaluate therapeutic responses. |
| SW1463 | The SW1463 xenograft model is derived from human rectal squamous cell carcinoma and is used to study aggressive colorectal cancers and test novel therapies. |
| Colo678 | The Colo678 xenograft model is derived from human colon carcinoma and is used in preclinical studies of colon cancer progression and drug efficacy. |
| NCI-H508 | The NCI-H508 xenograft model is derived from human colorectal adenocarcinoma and is used to study EGFR-targeted therapies and drug resistance mechanisms. |
| HCT-8 | The HCT-8 xenograft model is derived from human ileocecal adenocarcinoma and is used to evaluate therapies targeting metastatic gastrointestinal tumors. |
| RCM1 | The RCM1 xenograft model is derived from human colorectal carcinoma and is used to study tumor growth dynamics and screen novel anticancer agents. |
| LS513 | The LS513 xenograft model is derived from human colorectal cancer and is used to investigate chemoresistance and assess experimental treatments. |
| MDST8 | The MDST8 xenograft model is derived from human colorectal carcinoma and is used to study aggressive tumor behavior and therapeutic intervention. |
| LS1034 | The LS1034 xenograft model is derived from human colon adenocarcinoma and is used to study chemotherapy response and genetic alterations in colon cancer. |
| SW948 | The SW948 xenograft model is derived from human colorectal adenocarcinoma and is used to evaluate therapies for moderately differentiated colon tumors. |